Gumus M, Chen CI, Ivanescu C, Kilickap S, et al. Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of >/=50%: The EMPOWER-Lung 1 study. Cancer 2022 Oct 29. doi: 10.1002/cncr.34477.
PMID: 36308296